The Regulatory Shift in Peptides: FDA Advisory Committee Recommends Compounding Despite Safety Warnings
"The recommendation to allow compounding of select peptides marks a significant regulatory shift that provides a safer alternative to the black market, yet it simultaneously bypasses the gold standard of…